Everything Jim Cramer on 'Mad Money,' including Trump impeachment, Bob Iger chat, new GW Pharma drug
, Iger pulled back the curtain on his thought process when Disney considered buying the social media platform in 2016.
"Well, I got cold feet for the right reasons. ... I thought we'd be taking on responsibility that we shouldn't take on" because "it was too complex in terms of Twitter's place in the world," Iger explained to Cramer.GW Pharma has been cleared to market the first plant-derived cannabis-based medicine in Europe to treat epilepsy conditions, CEO Justin Gover told Cramer.
European Union officials this week approved the use of Epidyolex to treat seizures in patients with two rare, severe forms of childhood-onset epilepsy and GW Pharma executives are optimistic about its prospects across the pond.. "We'll be launching these countries over the next year or two and there's a market of 500 million people in Europe and we're very excited.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Jim Cramer says Netflix 'has become an open sore to this market'The once-beloved Netflix is now negative for the year as investors start to question some of the high-flying leaders of this bull market.
Consulte Mais informação »
Jim Cramer on the impact of impeachment on the market: 'We've seen this movie before''I say there's no hurry to start buying here, although … history says that you're going to have to try to pull the trigger soon, rather than be left behind,' CNBC's Jim Cramer says.
Consulte Mais informação »
Disney CEO Bob Iger tells Jim Cramer why he had second thoughts on a Twitter deal — 'I got cold feet for the right reasons''There are things Disney shouldn't even try to do well and that was one of them,' Disney CEO Bob Iger says.
Consulte Mais informação »
Cramer rants against hyped-up IPOs such as WeWork — Peloton is just 'a way to hang your towels up'CNBC's Jim Cramer calls on investors to be wary of the slew of hyped-up unicorn companies going public this year and encourages the focus to be on deliverable earnings.
Consulte Mais informação »
Jim Cramer on the impact of impeachment on the market: 'We've seen this movie before''I say there's no hurry to start buying here, although … history says that you're going to have to try to pull the trigger soon, rather than be left behind,' CNBC's Jim Cramer says.
Consulte Mais informação »